Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Arno TherapeuticsARNI Selling, General, & Admin. Expense is $4.61 Mil as of Sep. 2016.
Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. Arno Therapeutics's selling, general, & admin. expense for the
three
months ended in Sep. 2016 was $1.12 Mil.
Its selling, general, & admin. expense for the trailing twelve months (TTM) ended in Sep. 2016 was $4.61 Mil.
Arno Therapeutics (OTCPK:ARNI) Selling, General, & Admin. Expense Explanation
An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.
Warren Buffett likes companies with consistent SGA as the percentage of gross profit.
Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.
If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.
Arno Therapeutics Selling, General, & Admin. Expense Related Terms
Arno Therapeutics Selling, General, & Admin. Expense Historical Data
* Premium members only.
The historical data trend for Arno Therapeutics's Selling, General, & Admin. Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arno Therapeutics Selling, General, & Admin. Expense Chart
ARNI vs PLPL, BTHE, WIZP: Selling, General, & Admin. Expense Comparison
For the Biotechnology subindustry, Arno Therapeutics's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arno Therapeutics Selling, General, & Admin. Expense vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Arno Therapeutics's Selling, General, & Admin. Expense distribution charts can be found below:
* The bar in red indicates where Arno Therapeutics's Selling, General, & Admin. Expense falls into.
Arno Therapeutics Selling, General, & Admin. Expense Calculation
Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.
Selling, General, & Admin. Expense for the trailing twelve months (TTM) ended in Sep. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.61 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Selling, General, & Admin. Expense of $4.61 Mil mean?
Arno Therapeutics (ARNI) has a Selling, General, & Admin. Expense of $4.61 Mil as of Sep. 2016. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on Arno Therapeutics and its competitors.
Is Arno Therapeutics' Selling, General, & Admin. Expense too high?
Arno Therapeutics' current Selling, General, & Admin. Expense is $4.61 Mil.
How does Arno Therapeutics' Selling, General, & Admin. Expense compare to PLPL and BTHE?
Arno Therapeutics' Selling, General, & Admin. Expense of $4.61 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Selling, General, & Admin. Expense for a Biotechnology company?
A good Selling, General, & Admin. Expense depends on the Biotechnology industry context. However, Selling, General, & Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Selling, General, & Admin. Expense mean?
A high Selling, General, & Admin. Expense can signal that a stock is expensive relative to its fundamentals. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on Arno Therapeutics and its competitors. Arno Therapeutics's current Selling, General, & Admin. Expense is $4.61 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arno Therapeutics stock overvalued right now?
Arno Therapeutics (ARNI) has a current Selling, General, & Admin. Expense of $4.61 Mil. The current Selling, General, & Admin. Expense is $4.61 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Selling, General, & Admin. Expense calculated?
Selling, General, & Admin. Expense is calculated from a company's financial statements. For Arno Therapeutics (ARNI), the current Selling, General, & Admin. Expense is $4.61 Mil as of Sep. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Arno Therapeutics Inc operates as a biopharmaceutical company. It develops drug candidates to treat patients with cancer and other life-threatening diseases. It develops pre-clinical and clinical-stage product under the following name: Onapristone, AR-42, and AR-12. Onapristone is indicated for endometrial, prostate and breast cancer indications, AR-42 is provided for hematological malignancies and solid tumors indications and AR-12 is offered for solid tumors and hematological malignancies, and various anti-microbial targets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ARNI has been successfully added to your 
